Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/12/2018 06/13/2018 06/14/2018 06/15/2018 06/18/2018 Date
145.54(c) 149.52(c) 150(c) 150(c) 146.04(c) Last
1 366 843 3 584 854 2 024 484 3 216 165 1 775 574 Volume
+0.23% +2.73% +0.32% 0.00% -2.64% Change
More quotes
Financials (USD)
Sales 2019 216 B
EBIT 2019 3 693 M
Net income 2019 2 011 M
Debt 2019 4 203 M
Yield 2019 0,93%
Sales 2020 224 B
EBIT 2020 3 791 M
Net income 2020 2 088 M
Debt 2020 2 592 M
Yield 2020 1,01%
P/E ratio 2019 15,28
P/E ratio 2020 13,80
EV / Sales2019 0,16x
EV / Sales2020 0,15x
Capitalization 30 951 M
More Financials
Company
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.It operates through the McKesson Distribution Solutions and McKesson Technology Solutions business segments.The McKesson... 
Sector
Drug Retailers
Calendar
06/28Investor Day
More about the company
Surperformance© ratings of McKesson Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on MCKESSON CORPORATION
11:13aMCKESSON : Prescribe Robust Distribution to Commercialize Your Orphan Drug
PU
06/13MCKESSON : Meet the Mind Behind Our Gene Therapy Product Strategy
PU
06/13GLOBAL COMPUTER ASSISTED CODING SOFT : This research, highlighting the current s..
AQ
06/11MCKESSON : Empower Your Hospital Pharmacy’s Supply Chain Through Data
PU
06/07MCKESSON CORPORATION : to Present at the Goldman Sachs 39th Annual Global Health..
AQ
06/06MCKESSON : Personal Capital Advisors Corp Trimmeds Holding in Mckesson Co. (Mck)
AQ
06/05MCKESSON : Completes Acquisition of Medical Specialties Distributors
AQ
06/04MCKESSON : The Right PSAO Partner Can Enhance Your Independent Pharmacy's Perfor..
PU
06/01MCKESSON : Completes Acquisition of Medical Specialties Distributors
BU
05/31MCKESSON : Reports Fiscal 2018 Fourth-Quarter and Full-Year Results
AQ
More news
Sector news : Drug Retailers - NEC
06/15WALGREENS BOOTS ALLIANCE : Theranos founder Holmes, former president indicted fo..
RE
06/13CARDINAL HEALTH : Clayton Dubilier & Rice to Buy 55% Stake in Cardinal Health's ..
DJ
06/07U.S. antitrust official says worries over limiting vertical deals 'misplaced'
RE
06/07CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture
RE
06/07CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture
RE
More sector news : Drug Retailers - NEC
4-Traders Strategies on MCKESSON CORPORATION 
MCKESSON CORPORATION - 2012
An appropriate purchase level
BUY
MCKESSON CORPORATION - 2012
In oversold situation
BUY
More Strategies
Latest Tweets
06/17McKesson Corporation closing Rocky Hill facility; over 100 layoffs anticipate..
1
06/17Investor coalitions finding success pushing drug makers on pricing and wholes.. 
06/16Analysts Anticipate McKesson Co. $MCK to Post $2.67 Earnings Per Share  
06/16Fixing our broken health care system has always been a priority. We must deli..
25
06/15Confident Investor indicator analysis for 6/15/2018. Interesting results from.. 
More tweets
Qtime:158
News from SeekingAlpha
08:00aMCKESSON : Attractive At $150 
05/30McKesson goes ex-dividend tomorrow 
05/25McKesson Corporation 2018 Q4 - Results - Earnings Call Slides 
05/25WALL STREET BREAKFAST, MAY 25TH : EU Data Privacy Rules Take Effect; U.S. And Ch.. 
05/25WALL STREET BREAKFAST : New Privacy Bar With GDPR 
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 169 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-3.82%30 951
CVS HEALTH CORPORATION-3.32%71 257
WALGREENS BOOTS ALLIANCE-9.39%65 252
EXPRESS SCRIPTS HOLDING CO9.53%45 921
AMERISOURCEBERGEN3.30%20 848
CARDINAL HEALTH-10.64%17 010